These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 8905171

  • 1. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J, Ritchie IM, Butcher SP, Kelly JS.
    Brain Res; 1996 Sep 30; 735(1):67-82. PubMed ID: 8905171
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
    Sharkey J, Ritchie IM, Butcher SP, Kelly JS.
    Brain Res; 1994 Jul 18; 651(1-2):27-36. PubMed ID: 7922575
    [Abstract] [Full Text] [Related]

  • 3. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
    Nakanishi H, Katsuta K, Ueda Y, Takasugi H, Kuno A, Ohkubo M, Ogita K, Yoneda Y, Shirakawa K, Yoshida K.
    Psychopharmacology (Berl); 1995 Jan 18; 117(2):172-7. PubMed ID: 7753964
    [Abstract] [Full Text] [Related]

  • 4. Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.
    Hodgkiss JP, Sherriffs HJ, Cottrell DA, Shirakawa K, Kelly JS, Kuno A, Ohkubo M, Butcher SP, Olverman HJ.
    Eur J Pharmacol; 1993 Aug 24; 240(2-3):219-27. PubMed ID: 7902282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K, Nakanishi H, Shirakawa K, Yoshida K, Takagi K, Tamura A.
    J Cereb Blood Flow Metab; 1995 Mar 24; 15(2):345-8. PubMed ID: 7860668
    [Abstract] [Full Text] [Related]

  • 11. Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.
    Hargreaves RJ, Rigby M, Smith D, Hill RG.
    Br J Pharmacol; 1993 Sep 24; 110(1):36-42. PubMed ID: 8220897
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA.
    Brain Res; 1999 Oct 02; 843(1-2):171-83. PubMed ID: 10528123
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
    Nehls DG, Kurumaji A, Park CK, McCulloch J.
    Neurosci Lett; 1988 Aug 31; 91(2):204-10. PubMed ID: 2847086
    [Abstract] [Full Text] [Related]

  • 15. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.
    Bakshi VP, Geyer MA.
    J Neurosci; 1998 Oct 15; 18(20):8394-401. PubMed ID: 9763482
    [Abstract] [Full Text] [Related]

  • 16. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
    Kurumaji A, McCulloch J.
    J Cereb Blood Flow Metab; 1989 Dec 15; 9(6):786-94. PubMed ID: 2684992
    [Abstract] [Full Text] [Related]

  • 17. Intracerebroventricular application of competitive and non-competitive NMDA antagonists induce similar effects upon rat hippocampal electroencephalogram and local cerebral glucose utilization.
    Boddeke HW, Wiederhold KH, Palacios JM.
    Brain Res; 1992 Jul 10; 585(1-2):177-83. PubMed ID: 1511299
    [Abstract] [Full Text] [Related]

  • 18. Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.
    Hashimoto K, Tomitaka S, Bi Y, Narita N, Minabe Y, Iyo M.
    Eur J Neurosci; 1997 Sep 10; 9(9):1891-901. PubMed ID: 9383212
    [Abstract] [Full Text] [Related]

  • 19. Cerebral glucose utilization in transgenic mice overexpressing heat shock protein 70 is altered by dizocilpine.
    Kelly S, Bieneman A, Uney JB, McCulloch J.
    Eur J Neurosci; 2002 Mar 10; 15(6):945-52. PubMed ID: 11918653
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.
    Kurumaji A, Ikeda M, Dewar D, McCormack AG, McCulloch J.
    Brain Res; 1991 Nov 01; 563(1-2):57-65. PubMed ID: 1838495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.